Julia Remnestål

Julia Remnestål has a diverse work experience. Julia began their career in 2012 as a Laboratory Engineer at Karolinska University Hospital. In 2013, they worked as a Course Assistant at Stockholm School of Entrepreneurship. From 2014 to 2015, they worked as a Laboratory Engineer at KTH Royal Institute of Technology and as a Laboratory Technician, Master Thesis Student, Researcher, and Research Engineer at Affinity Proteomics, Kungliga Tekniska högskolan. In 2020, they became a Regulatory Affairs Specialist at CarryGenes Therapeutics AB and in 2023, they were promoted to Regulatory Affairs Manager at XNK Therapeutics.

Julia Remnestål obtained their Doctor of Philosophy - PhD in Biotechnology and Proteomics from KTH Royal Institute of Technology between 2016 and 2020. Julia also obtained their Master of Science (MSc) in Medical Biotechnology from KTH Royal Institute of Technology between 2010 and 2015. Her educational history prior to 2010 is unknown, but it is known that they attended Marina Läroverket between 2006 and 2009.